PRRT2 and glomerulosclerosis: Additionally, irbesartan, as an ARB, also helps relieve proteinuria and delay glomerulosclerosis and tubulointerstitial fibrosis by regulating protein kinases C (PKC) and RAS (renin-angiotensin system) activity, inhibiting inflammatory response and reducing oxidative stress and injury to Sertoli cells.17,18